SEC Form 4 · accession 0001479791-18-000004
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Jan 5, 2018
Accepted (ET)
Jan 9, 2018 · 2:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Jan 5, 2018 | S | 50,000 | $0.12 | D | 25,625,763 | D | |
| INVO Bioscience Common Stock | Jan 5, 2018 | S | 20,000 | $0.125 | D | 26,605,763 | D | |
| INVO Bioscience Common Stock | Jan 8, 2018 | S | 30,000 | $0.144 | D | 25,575,763 | D |
Table II — derivative securities
No Table II lines on this filing.